AllianceBernstein’s Kestra Medical Technologies KMTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.5M Buy
1,477,992
+157,618
+12% +$3.3M 0.01% 790
2026
Q1
$35M Sell
1,320,374
-105,681
-7% -$2.49M 0.01% 712
2025
Q4
$37.8M Sell
1,426,055
-65,915
-4% -$1.7M 0.01% 713
2025
Q3
$35.4M Buy
1,491,970
+179,885
+14% +$3.22M 0.01% 719
2025
Q2
$21.8M Buy
1,312,085
+128,312
+11% +$2.8M 0.01% 873
2025
Q1
$29.5M Buy
+1,183,773
New +$27.2M 0.01% 748

Other funds holding KMTS

AllianceBernstein's KMTS Position: Q2 2026 in Review

AllianceBernstein increased its Kestra Medical Technologies (KMTS) stake by 12% in Q2 2026, buying an estimated $3.3M and bringing the position to 1,477,992 shares worth $29.5M. The position accounts for 0.01% of the portfolio, ranked #790.

AllianceBernstein first reported a position in KMTS in Q1 2025 and has held it in 6 quarters since. The position peaked at $37.8M in Q4 2025. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • AllianceBernstein held 1,477,992 shares of Kestra Medical Technologies worth $29.5M as of Q2 2026.
  • AllianceBernstein bought 157,618 Kestra Medical Technologies shares in Q2 2026, an estimated $3.3M.
  • Kestra Medical Technologies made up 0.01% of AllianceBernstein's portfolio in Q2 2026, its #790 holding.
  • AllianceBernstein first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 6 quarters since.
  • AllianceBernstein's Kestra Medical Technologies position peaked at $37.8M in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.